PharmaShots | Incisive News in 3 Shots

Subscribe Now

Neurofibromatosis Type 1 Plexiform Neurofibromas

AstraZeneca and MSD's Selumetinib Receive EU's CHMP Positive Opinion as the First Therapy for Pediatric Patients with Neurofibromatosis Type 1 Plexiform Neurofibromas

AstraZeneca and MSD's Selumetinib Receive EU's CHMP Positive Opinion as the First Therapy for Pediatric Patients with Neurofibroma...

April 26, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us